Logo image of BCOV

BRIGHTCOVE (BCOV) Stock Fundamental Analysis

NASDAQ:BCOV - Nasdaq - US10921T1016 - Common Stock - Currency: USD

4.45  +0.01 (+0.23%)

After market: 4.45 0 (0%)

Fundamental Rating

3

BCOV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 81 industry peers in the IT Services industry. The financial health of BCOV is average, but there are quite some concerns on its profitability. BCOV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BCOV was profitable.
In the past year BCOV had a positive cash flow from operations.
BCOV had negative earnings in 4 of the past 5 years.
Each year in the past 5 years BCOV had a positive operating cash flow.
BCOV Yearly Net Income VS EBIT VS OCF VS FCFBCOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

BCOV has a Return On Assets (-4.34%) which is in line with its industry peers.
BCOV has a Return On Equity (-9.58%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.34%
ROE -9.58%
ROIC N/A
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
BCOV Yearly ROA, ROE, ROICBCOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

BCOV's Gross Margin of 61.60% is amongst the best of the industry. BCOV outperforms 81.01% of its industry peers.
BCOV's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BCOV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
BCOV Yearly Profit, Operating, Gross MarginsBCOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BCOV has more shares outstanding
BCOV has more shares outstanding than it did 5 years ago.
There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BCOV Yearly Shares OutstandingBCOV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BCOV Yearly Total Debt VS Total AssetsBCOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

BCOV has an Altman-Z score of 0.08. This is a bad value and indicates that BCOV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.08, BCOV is not doing good in the industry: 83.54% of the companies in the same industry are doing better.
There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.08
ROIC/WACCN/A
WACC10.73%
BCOV Yearly LT Debt VS Equity VS FCFBCOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

BCOV has a Current Ratio of 0.75. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.
BCOV has a worse Current ratio (0.75) than 88.61% of its industry peers.
BCOV has a Quick Ratio of 0.75. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BCOV (0.75) is worse than 88.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
BCOV Yearly Current Assets VS Current LiabilitesBCOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.45% over the past year.
The Revenue has decreased by -0.22% in the past year.
Measured over the past years, BCOV shows a small growth in Revenue. The Revenue has been growing by 4.07% on average per year.
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%

3.2 Future

BCOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.74% yearly.
Based on estimates for the next years, BCOV will show a small growth in Revenue. The Revenue will grow by 0.01% on average per year.
EPS Next Y100%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.51%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BCOV Yearly Revenue VS EstimatesBCOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
BCOV Yearly EPS VS EstimatesBCOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 0 0.2 -0.2 0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 89.00, the valuation of BCOV can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BCOV is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.45. BCOV is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 124.65, BCOV can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BCOV is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, BCOV is valued quite expensively.
Industry RankSector Rank
PE 89
Fwd PE 124.65
BCOV Price Earnings VS Forward Price EarningsBCOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

BCOV's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BCOV is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 51.96
EV/EBITDA 23.8
BCOV Per share dataBCOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BCOV's earnings are expected to grow with 64.74% in the coming years.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y64.74%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BCOV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRIGHTCOVE

NASDAQ:BCOV (2/3/2025, 8:15:51 PM)

After market: 4.45 0 (0%)

4.45

+0.01 (+0.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners70.58%
Inst Owner Change-99.26%
Ins Owners5.23%
Ins Owner Change-159.4%
Market Cap201.05M
Analysts45.71
Price Target4.54 (2.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)56.43%
Max EPS beat(2)143.57%
EPS beat(4)4
Avg EPS beat(4)114.38%
Min EPS beat(4)56.43%
Max EPS beat(4)161.44%
EPS beat(8)6
Avg EPS beat(8)77.66%
EPS beat(12)10
Avg EPS beat(12)100.79%
EPS beat(16)14
Avg EPS beat(16)114.38%
Revenue beat(2)2
Avg Revenue beat(2)0.71%
Min Revenue beat(2)0.56%
Max Revenue beat(2)0.87%
Revenue beat(4)2
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)6
Avg Revenue beat(12)-0.14%
Revenue beat(16)10
Avg Revenue beat(16)0.35%
PT rev (1m)0%
PT rev (3m)14.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)N/A
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 89
Fwd PE 124.65
P/S 1.01
P/FCF 51.96
P/OCF 14.73
P/B 2.11
P/tB 11.84
EV/EBITDA 23.8
EPS(TTM)0.05
EY1.12%
EPS(NY)0.04
Fwd EY0.8%
FCF(TTM)0.09
FCFY1.92%
OCF(TTM)0.3
OCFY6.79%
SpS4.42
BVpS2.11
TBVpS0.38
PEG (NY)0.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.34%
ROE -9.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.6%
FCFM 1.94%
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
F-Score7
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 50.16%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion 186.6%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 0.08
F-Score7
WACC10.73%
ROIC/WACCN/A
Cap/Depr(3y)143.44%
Cap/Depr(5y)123.4%
Cap/Sales(3y)7.87%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y100%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%
Revenue Next Year-1.51%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year979.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.43%
OCF growth 3Y-40.43%
OCF growth 5Y12.05%